Equities

Viemed Healthcare Inc

Viemed Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)6.60
  • Today's Change0.05 / 0.76%
  • Shares traded25.54k
  • 1 Year change-32.99%
  • Beta1.4943
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).

  • Revenue in USD (TTM)194.05m
  • Net income in USD10.33m
  • Incorporated2016
  • Employees996.00
  • Location
    Viemed Healthcare Inc625 E. KALISTE SALOOM RD.LAFAYETTE 70508United StatesUSA
  • Phone+1 (337) 504-3802
  • Fax+1 (337) 500-1972
  • Websitehttps://www.viemed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zomedica Corp25.97m-37.31m142.09m144.00--0.6128--5.47-0.0381-0.03810.02650.23660.09922.1413.17180,319.40-14.26-14.03-14.73-14.4567.78---143.67-220.9810.87--0.00--33.05---102.93--89.85--
DLH Holdings Corp402.59m3.07m153.00m3.20k54.551.437.570.380.1970.19727.687.501.17--6.57125,807.800.89245.381.117.2020.9220.560.76313.41--1.500.60690.00-4.8823.05-93.73-28.16-0.903--
Longduoduo Co Ltd8.78m1.77m164.73m--92.96413.8779.5018.770.05910.05910.29230.01335.06453.60134.94--114.14------95.04--22.55--1.04--0.00--17.93--99.48------
Biodesix Inc54.85m-47.06m181.20m217.00------3.30-0.5465-0.54650.6308-0.05660.653--7.42252,760.40-56.02-55.60-82.08-80.9476.2759.53-85.80-105.15---3.711.18--28.4619.1620.32--106.31--
23andMe Holding Co.219.64m-666.70m192.08m560.00--1.02--0.8745-1.39-1.390.46150.38460.328410.5984.14392,210.70-99.67---125.67--45.2546.35-303.55-121.631.91--0.00---26.66-13.01-113.92---19.09--
Joint Corp119.12m-11.13m200.50m444.00--7.64--1.68-0.7556-0.75568.041.751.29--35.08268,283.10-12.014.32-17.556.0590.9490.28-9.343.68--1,198.660.0022--16.2426.27-1,656.09--35.09--
Airsculpt Technologies Inc197.72m1.56m226.83m346.00163.212.7118.421.150.02410.02413.431.450.9593--136.64571,456.600.7588--0.8478--65.54--0.791----4.020.4602--16.07--69.49------
Viemed Healthcare Inc194.05m10.33m254.28m996.0025.672.197.541.310.25520.25524.793.001.3919.369.51194,824.307.3912.289.1415.5261.1162.575.3210.091.14146.040.05520.0031.8223.2164.631.5033.67--
Accolade Inc431.53m-88.99m278.31m2.40k--0.6394--0.6449-1.16-1.165.655.520.5253--15.98179,805.00-10.83-24.80-12.43-29.0447.4945.56-20.62-56.43----0.3242--14.0934.3078.29--31.97--
DocGo Inc703.37m21.55m303.68m2.92k15.200.98897.310.43180.19680.19686.553.021.57--3.39241,294.505.47--7.92--32.83--3.49------0.1192--41.72---80.17------
QDM International Inc6.53m1.69m352.79m3.0031.80108.32205.8854.000.0380.0380.02960.01121.81--148.49--46.82--127.17--38.10--25.81----1,761.140.2722--1,542.96--111.78------
Talkspace Inc162.13m-11.89m369.81m472.00--3.09--2.28-0.0716-0.07160.97210.70521.15--13.80343,485.20-8.40---9.68--48.95---7.33------0.00--25.49--75.92------
Data as of Jul 03 2024. Currency figures normalised to Viemed Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

40.11%Per cent of shares held by top holders
HolderShares% Held
Thrivent Asset Management LLCas of 31 Dec 20233.35m8.62%
BlackRock Fund Advisorsas of 31 Mar 20242.19m5.64%
The Vanguard Group, Inc.as of 31 May 20241.78m4.59%
Forager Capital Management LLCas of 31 Mar 20241.72m4.42%
Nantahala Capital Management LLCas of 31 Mar 20241.55m3.99%
AWM Investment Co., Inc.as of 31 Mar 20241.43m3.68%
Wasatch Advisors LPas of 31 Mar 20241.16m3.00%
Cove Street Capital LLCas of 31 Mar 2024893.80k2.30%
Geode Capital Management LLCas of 31 Mar 2024751.56k1.94%
Punch & Associates Investment Management, Inc.as of 31 Mar 2024745.69k1.92%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.